Cytokines and Chemokines in Mycobacterium tuberculosis Infection

R Domingo-Gonzalez, O Prince, A Cooper… - Microbiology …, 2016 - journals.asm.org
Chemokines and cytokines are critical for initiating and coordinating the organized and
sequential recruitment and activation of cells into Mycobacterium tuberculosis-infected …

CXCR3 in T cell function

JR Groom, AD Luster - Experimental cell research, 2011 - Elsevier
CXCR3 is a chemokine receptor that is highly expressed on effector T cells and plays an
important role in T cell trafficking and function. CXCR3 is rapidly induced on naïve cells …

CXCR3 ligands: redundant, collaborative and antagonistic functions

JR Groom, AD Luster - Immunology and cell biology, 2011 - Wiley Online Library
CXCR3 is a chemokine receptor that is rapidly induced on naïve T cells following activation,
and preferentially remains highly expressed on type‐1 helper (Th1)‐type CD4+ T cells …

Biomarkers and diagnostics for tuberculosis: progress, needs, and translation into practice

RS Wallis, M Pai, D Menzies, TM Doherty, G Walzl… - The lancet, 2010 - thelancet.com
Human infection with Mycobacterium tuberculosis can progress to active disease, be
contained as latent infection, or be eradicated by the host response. Tuberculosis …

Update on tuberculosis biomarkers: from correlates of risk, to correlates of active disease and of cure from disease

D Goletti, MR Lee, JY Wang, N Walter… - …, 2018 - Wiley Online Library
Tuberculosis (TB) remains a devastating disease, yet despite its enormous toll on global
health, tools to control TB are insufficient and often outdated. TB Biomarkers (TB‐BM) would …

Beyond the IFN-γ horizon: biomarkers for immunodiagnosis of infection with Mycobacterium tuberculosis

NN Chegou, J Heyckendorf, G Walzl… - European …, 2014 - publications.ersnet.org
Latent infection with Mycobacterium tuberculosis (LTBI) is defined by the presence of M.
tuberculosis-specific immunity in the absence of active tuberculosis. LTBI is detected using …

Immune biomarkers for diagnosis and treatment monitoring of tuberculosis: current developments and future prospects

YK Yong, HY Tan, A Saeidi, WF Wong… - Frontiers in …, 2019 - frontiersin.org
Tuberculosis (TB) treatment monitoring is paramount to clinical decision-making and the
host biomarkers appears to play a significant role. The currently available diagnostic …

Tuberculosis biomarkers: from diagnosis to protection

D Goletti, E Petruccioli, SA Joosten… - Infectious disease …, 2016 - pmc.ncbi.nlm.nih.gov
New approaches to control tuberculosis (TB) worldwide are needed. In particular, new tools
for diagnosis and new biomarkers are required to evaluate both pathogen and host key …

[HTML][HTML] Importance of IP-10 as a biomarker of host immune response: Critical perspective as a target for biosensing

S Madhurantakam, ZJ Lee, A Naqvi… - Current Research in …, 2023 - Elsevier
While the exploration into biomolecules for diagnostic and prognostic devices continues to
develop, many molecules continue to be examined for individual diseases or treatments …

Mycobacterium tuberculosis-specific cytokine biomarkers to differentiate active TB and LTBI: A systematic review

EL Sudbury, V Clifford, NL Messina, R Song, N Curtis - Journal of Infection, 2020 - Elsevier
Objectives New tests are needed to overcome the limitations of existing immunodiagnostic
tests for tuberculosis (TB) infection, including their inability to differentiate between active TB …